Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
62,587,229
-
Share change
-
+1,470,574
-
Total reported value
-
$455,008,320
-
Put/Call ratio
-
1.9%
-
Price per share
-
$7.27
-
Number of holders
-
113
-
Value change
-
+$10,612,601
-
Number of buys
-
53
-
Number of sells
-
50
Institutional Holders of POINT BIOPHARMA GLOBAL INC - COM (PNT) as of Q1 2023
As of 31 Mar 2023,
POINT BIOPHARMA GLOBAL INC - COM (PNT) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,587,229 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, PFM Health Sciences, LP, CITADEL ADVISORS LLC, STATE STREET CORP, Point72 Asset Management, L.P., Rubric Capital Management LP, and Boxer Capital, LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.